Carderock Capital Management’s Danaher DHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211K Sell
1,106
-24,345
-96% -$4.42M 0.05% 66
2026
Q1
$4.83M Buy
25,451
+986
+4% +$210K 1.19% 42
2025
Q4
$5.6M Buy
24,465
+3,362
+16% +$739K 1.36% 38
2025
Q3
$4.18M Buy
21,103
+1,375
+7% +$274K 1.02% 46
2025
Q2
$3.9M Buy
19,728
+271
+1% +$52.6K 1% 46
2025
Q1
$3.99M Sell
19,457
-226
-1% -$49.3K 1.06% 44
2024
Q4
$4.52M Sell
19,683
-1,595
-7% -$392K 1.13% 44
2024
Q3
$5.92M Buy
21,278
+154
+0.7% +$40.8K 1.4% 43
2024
Q2
$5.28M Buy
21,124
+720
+4% +$182K 1.38% 41
2024
Q1
$5.1M Sell
20,404
-6,000
-23% -$1.46M 1.43% 37
2023
Q4
$6.11M Sell
26,404
-2,939
-10% -$625K 1.69% 34
2023
Q3
$6.45M Buy
29,343
+1,081
+4% +$241K 2.17% 19
2023
Q2
$6.01M Buy
28,262
+2,075
+8% +$439K 1.86% 27
2023
Q1
$5.85M Sell
26,187
-94
-0.4% -$21.4K 2.04% 18
2022
Q4
$6.18M Buy
26,281
+414
+2% +$96K 2.56% 10
2022
Q3
$5.92M Sell
25,867
-8,287
-24% -$2.03M 3.02% 7
2022
Q2
$7.68M Sell
34,154
-1,332
-4% -$307K 3.21% 5
2022
Q1
$9.23M Sell
35,486
-5,520
-13% -$1.38M 2.98% 5
2021
Q4
$12M Buy
41,006
+1,608
+4% +$443K 2.87% 7
2021
Q3
$10.6M Buy
39,398
+180
+0.5% +$49K 3% 7
2021
Q2
$9.33M Sell
39,218
-636
-2% -$141K 2.56% 8
2021
Q1
$7.95M Sell
39,854
-380
-0.9% -$77.2K 2.38% 9
2020
Q4
$7.92M Buy
40,234
+161
+0.4% +$32.3K 2.39% 12
2020
Q3
$7.65M Buy
40,073
+112
+0.3% +$19.9K 2.58% 9
2020
Q2
$6.26M Sell
39,961
-204
-0.5% -$29.3K 2.31% 12
2020
Q1
$4.93M Sell
40,165
-11,880
-23% -$1.6M 2.26% 14
2019
Q4
$7.08M Buy
52,045
+268
+0.5% +$33.9K 2.38% 9
2019
Q3
$6.63M Sell
51,777
-223
-0.4% -$27.9K 2.44% 8
2019
Q2
$6.59M Buy
52,000
+4,575
+10% +$542K 2.49% 6
2019
Q1
$5.55M Sell
47,425
-401
-0.8% -$41.1K 2.26% 14
2018
Q4
$4.37M Sell
47,826
-1,830
-4% -$166K 2.26% 17
2018
Q3
$4.78M Buy
49,656
+320
+0.6% +$29.1K 1.89% 20
2018
Q2
$4.32M Buy
49,336
+65
+0.1% +$5.79K 1.86% 20
2018
Q1
$4.28M Buy
49,271
+95
+0.2% +$8.31K 1.89% 21
2017
Q4
$4.05M Sell
49,176
-206
-0.4% -$16.8K 1.78% 23
2017
Q3
$3.75M Sell
49,382
-14,643
-23% -$1.08M 1.69% 28
2017
Q2
$4.79M Buy
64,025
+27
+0% +$2.02K 2.16% 16
2017
Q1
$4.85M Sell
63,998
-301
-0.5% -$22.4K 2.25% 13
2016
Q4
$4.44M Sell
64,299
-280
-0.4% -$19.4K 2.21% 14
2016
Q3
$4.49M Sell
64,579
-19,829
-23% -$1.41M 2.25% 16
2016
Q2
$5.73M Sell
84,408
-3,268
-4% -$214K 3.03% 3
2016
Q1
$5.59M Sell
87,676
-1,633
-2% -$97.4K 2.87% 7
2015
Q4
$5.58M Buy
89,309
+2,774
+3% +$174K 2.9% 6
2015
Q3
$4.96M Buy
86,535
+31
+0% +$1.83K 2.76% 8
2015
Q2
$4.98M Buy
86,504
+1,404
+2% +$80.4K 2.5% 10
2015
Q1
$4.86M Buy
85,100
+930
+1% +$53.4K 2.35% 12
2014
Q4
$4.85M Buy
84,170
+823
+1% +$44.6K 2.39% 10
2014
Q3
$4.26M Buy
83,347
+6,698
+9% +$344K 2.18% 14
2014
Q2
$4.06M Buy
76,649
+1,371
+2% +$70.4K 2.12% 17
2014
Q1
$3.79M Sell
75,278
-1,598
-2% -$81.3K 1.93% 18
2013
Q4
$3.99M Buy
76,876
+13,793
+22% +$678K 2.09% 16
2013
Q3
$2.94M Buy
63,083
+1,113
+2% +$50.5K 1.7% 22
2013
Q2
$2.64M Buy
+61,970
New +$2.57M 1.56% 26

Other funds holding DHR

Carderock Capital Management's DHR Position: Q2 2026 in Review

Carderock Capital Management reduced its Danaher (DHR) stake by 96% in Q2 2026, selling an estimated $4.42M and leaving 1,106 shares worth $211K. The position accounts for 0.05% of the portfolio, ranked #66.

Carderock Capital Management first reported a position in DHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $12M in Q4 2021. 908 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • Carderock Capital Management held 1,106 shares of Danaher worth $211K as of Q2 2026.
  • Carderock Capital Management sold 24,345 Danaher shares in Q2 2026, an estimated $4.42M.
  • Danaher made up 0.05% of Carderock Capital Management's portfolio in Q2 2026, its #66 holding.
  • Carderock Capital Management first reported a position in Danaher in Q2 2013 and has held it in 53 quarters since.
  • Carderock Capital Management's Danaher position peaked at $12M in Q4 2021.
  • 908 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on Carderock Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.